Overview

TTI has chosen to focus its research and development efforts on the immune system and its regulation.

The human immune system consists of a highly regulated series of molecular and cellular components. Normally, these components coordinate rapid responses that protect the body from dangerous invaders. However, such a sophisticated system is also vulnerable to dysregulation and malfunction. The consequences of a dysfunctional immune system can be severe, and it is now appreciated that this contributes to a large spectrum of human diseases and disorders.

Trillium's core focus is on developing novel therapeutics based upon key regulatory pathways in the immune system. Our products target a range of serious diseases in the areas of autoimmunity, inflammation and cancer. Outside of this core area, Trillium also has an interest in growth factors targeting the epithelium of the bladder and GI tract.